These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34744419)

  • 1. Putative role of prosthetic dental implants in the development of cardiac sarcoidosis: A case-control study.
    Subramanian M; Bera D; Theodore J; Kishore J; Srinivas A; Saggu D; Yalagudri S; Narasimhan C
    Sarcoidosis Vasc Diffuse Lung Dis; 2021; 38(3):e2021023. PubMed ID: 34744419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
    Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
    Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
    Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-Treatment Myocardial
    Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of serial quantitative evaluation of
    Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
    Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
    Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
    Schildt JV; Loimaala AJ; Hippeläinen ET; Ahonen AA
    Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):293-298. PubMed ID: 28950301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke in cardiac sarcoidosis: Need to worry?
    Subramanian M; Yalagudri S; Saggu D; Kishore J; Reddy M; Narasimhan C
    Indian Heart J; 2020; 72(5):442-444. PubMed ID: 33189209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
    Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia.
    Nery PB; Mc Ardle BA; Redpath CJ; Leung E; Lemery R; Dekemp R; Yang J; Keren A; Beanlands RS; Birnie DH
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):364-74. PubMed ID: 24102263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
    Elwazir M; Krause ML; Bois JP; Christopoulos G; Kendi AT; Cooper JLT; Jouni H; Abouezzeddine OF; Chareonthaitawee P; Abdelshafee M; Amin S
    J Card Fail; 2022 Feb; 28(2):247-258. PubMed ID: 34320381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis.
    Ishiyama M; Soine LA; Vesselle HJ
    EJNMMI Res; 2017 Aug; 7(1):67. PubMed ID: 28822108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Patlak Ki images from
    Nakajo M; Ojima S; Kawakami H; Tani A; Hirayama A; Jinguji M; Kubozono T; Ohishi M; Yoshiura T
    Sci Rep; 2021 Feb; 11(1):2729. PubMed ID: 33526847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.